Navigation Links
Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results
Date:3/23/2009

r forward-looking statements do not reflect the potential impact of any future in-licensing, collaborations, acquisitions, mergers, dispositions, joint ventures or investments we may enter into or make. We do not assume any obligation to update any forward-looking statements, except as required by law.



    Transcept Pharmaceuticals, Inc.
    Statements of Operations

                                               Three Months Ended December 31,
                                               ------------------------------
                                                       2008          2007
                                                       ----          ----
    Operating expenses:
      Research and development                      $1,536,398    $3,548,188
      General and administrative                     2,558,779     1,453,214
      Merger related transaction costs               1,966,763             -
                                                     ---------           ---
    Total operating expenses                         6,061,940     5,001,402
                                                     ---------     ---------
    Loss from operations                            (6,061,940)   (5,001,402)
    Interest income                                     59,712       477,778
    Interest expense                                  (147,382)     (268,307)
    Other income (expense), net                         30,239        25,854
    Interest expense related to bridge loan warrants         -             -
                                                           ---           ---
    Net loss                                        (6,119,371)   (4,766,077)
    Deemed dividend - Series C convertible
     preferred stockholders                                  -             -
                                                           ---           ---
    Loss attributable to common stockhold
'/>"/>
SOURCE  Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 

Related medicine news :

1. Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results
2. Transcept Pharmaceuticals to Present at Two Upcoming Conferences
3. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
4. Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel
5. Transcept Pharmaceuticals, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
6. Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
7. Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
8. Transcept Pharmaceuticals to Present at Cowen and Companys 27th Annual Health Care Conference in Boston
9. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
10. Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
11. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Post Your Comments:
*Name:
*Comment:
*Email: